Clinical trial
Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in…
NCT00488514 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00488514 |
|---|---|
| Title | Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents |
| Official title | Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Disorders |
| Intervention type | Drug |
| Interventions | Combination Tablet of Treximet (sumatriptan/naproxen sodium) |
| Enrollment | 656 |
| Start date | Jul 13, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 20, 2009 |
| First posted | Jun 20, 2007 |
| Last update posted | May 18, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: